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Although the presence in convalescent human sera of type-specific antibodies 
to  group  A  streptococci has  been  reported  by several  workers  (1-10),  the 
specificity has  not  always  been  supported  by  unequivocal  evidence.  The 
newer knowledge of the different types of group A streptococci provided by 
Lancefield  (11,  12) and  Griffith  (13),  and  of the antigenic  structure  by the 
former, has made possible a new approach to the problem. 
A reliable and sensitive method of determining type-specific circulating anti- 
bodies would help greatly in solving  the  question of type-specific immunity; 
it would also provide a technique for investigating epidemiological  and clinical 
problems resulting  from  streptococcal infections and  their  sequelae.  Type- 
specific antibodies in the blood of patients recovering from group A strepto- 
coccal infections have been investigated by a variety of methods: agglutina- 
tion, precipitation I complement fixation,  mouse protection, opsonic,  and bac- 
teriostatic  techniques.  Both  slide  and  macroscopic  agglutination  reactions 
have  proved  unsatisfactory  because  of non-type-specific reactions  and  also 
because of the difficulty in obtaining uniformly stable bacterial suspensions. 
Precipitin  and  complement fixation  tests with  human  sera  and  M  extracts 
reveal many cross-reactions with extracts of heterologous types.  The mouse 
protection test requires strains of high mouse virulence which are infrequent in 
streptococci freshly isolated from human sources; this test apparently requires 
a higher antibody content than that usually found in convalescent human sera; 
moreover, large  amounts of sera are necessary.  The opsonic  index technique 
is frequently difficult to interpret.  The ba~teriostatic test, although dependent 
upon the opsonization by the serum and phagocytosis of the streptococcal cell 
byleukocytes, has yielded reliable and easily interpreted information concern- 
Lug the presence of type-specific antibodies.  In conformity with previous in- 
vestigators, the term bacteriostasis used in this report implies not merely the 
inhibition  of bacterial growth but also the destruction of microorganisms  by 
sensitization  with convalescent serum and their  subsequent phagocytosis by 
leukocytes. 
93 94  EFFECT  OF HUMAN  SERA ON  GROLrP A  STREPTOCOCCI.  I 
Recently, Kuttner  and Lenert (14), using both the direct and indirect meth- 
ods for bacteriostasis, were able to show the presence of type-specific antibodies 
in the blood of children convalescent from group A  streptococcal pharyngitis. 
In  the  direct  technique,  which  yielded  better  results  in  their  studies,  whole 
blood  from  the  infected  patient  is  used;  and  in  the  indirect  method,  whole 
blood, with no bacteriostatic activity against the streptococci under considera- 
tion, is obtained from a  control and added to the serum being tested. 
The  object  of the present study  was  to determine  whether,  by  the indirect 
method,  type-specific  antibodies  could  be  demonstrated  in  the  sera  of  adult 
patients  convalescent  from  group  A  streptococcal  infections. 
Materials and Methods 
Source of Sera.--Samples of sera were obtained at weekly intervals from 3 patients during 
periods  of  38,  7½,  and 37 weeks respectively, and stored without preservative at 4 ° C.  for 
one-half  to  two  years  before  testing.  Sera  taken  at  varying intervals  were  selected  for 
detailed study. 
The first patient (H.  A.,  No.  11,387),  a  man aged 20, was admitted on the 3rd day of 
scarlet fever.  Group A, type 6 streptococci, strain 1RSC86, were cultured from his nose and 
throat.  Because  he  developed  a  severe  primary  attack  of  rheumatic  fever,  observatior~ 
continued for 38 weeks. 
The second patient (E. B., No. 11,302),  a  man aged 37, entered the hospital on the 7th 
day  of scarlet fever.  Group A,  type  19 streptococci,  strain  1RSC42,  were  cultured from 
the nose and throat.  He was discharged 7½ weeks after onset of his illness. 
The third patient (C. DeM., No. 7500), a woman aged 20, known to have rheumatic heart 
disease, entered the hospital on the 3rd day of the fourth definite attack of rheumatic fever. 
This had been preceded by a  sore throat 15 days before.  Group A,  type 26 streptococci, 
strain C  118, were cultured from the throat.  She was observed for 37 weeks. 
Streptococcal Strains  Employed.--The  hemolytic  streptococci  recovered  from  the  naso- 
pharyngeal cultures of the patients on admission were dried from the frozen state (15).  Other 
strains were selected because of their antigenic composition (12)  from laboratory stock cul- 
tures which had been preserved in the dried state, often for many years.  All strains were in 
the matt phase, belonged to group A, and were typed by the precipitin method (16,  17). 
Preparation of Cultures.--Cultures  of  different dissociative states of  the same strain of 
streptococci showed varying susceptibility to bacteriostasis by normal human whole blood: 
the  glossy  variant was  the  most  susceptible;  the  mouse  virulent matt variant,  the  most 
resistant; and the matt variant which was avirulent for mice was intermediate in its resistance 
to phagocytosis.  When strains freshly isolated from patients were available, they were used 
with as  few  subcultures as  possible from  the original strain and without respect to  their 
virulence for mice.  When old stock cultures were used,  the mouse virulent strain derived 
from the original mouse passage was 'selected as being most suitable.  To maintain the matt 
phase, each strain was taken from the frozen dried stock, seeded into 5 cc.  of blood broth, 
and incubated at 37  ° C. in a water bath for 4 hours.  One cc. of this young culture was inocu- 
lated into 500 cc.  of Todd-Hewitt broth and incubated for 12 hours, then centrifuged; the 
streptococci were resuspended in 2 cc.  of broth and distributed in 0.2 cc. portions into each 
of 10 glass tubes, which were kept in the CO2 ice chest at -- 72  ° C. 
The day before each experiment the contents of one tube were warmed and pipetted into 
5 cc.  of blood broth, which was incubated in a water bath at 37  ° C. for 4 hours; 0.5 cc. was 
inoculated into 45 cc.  of Todd-Hewitt broth and grown for 10 to  12 hours.  To avoid any SIDNEY I~OTIIBARD  95 
antiphagocytic effect of the metabolic products of growth in the culture broth, the strepto- 
cocci were centrifuged and resuspended to  original volume in fresh broth.  Tenfold serial 
dilutions of the culture were made in broth, and the number of streptococci per cubic centi- 
meter calculated by pouring rabbit blood agar plates containing 0.5 cc.  of 10  -7 or 10  -8 dilu- 
tions.  In all the experiments, from 20 to 30 colonies per cc. grew from the 10  -~ and 2 to 3 
from the 10- 8 dilutions. 
Source  of Blood.--In  preliminary observations, it was  noted that both adult and fetal 
human blood often possessed bacteriostatic activity for the matt variants of group A strepto- 
cocci, but that the blood of afebrile children from 3 to 9 years of age, and free of any infection, 
did not have this bacteriostatic property.  These children had usually been hospitalized for 
an elective orthopedic or plastic operation.  1  When necessary, the blood from several chil- 
dren was pooled to provide a sufficient quantity.  Heparin (Connaught Laboratory, Toronto 
University) in a final dilution of 1:16,000 was used as an anticoagulant. 
Bact~iosta~  Test.--Since old, stored sera were employed in this study, it was necessary 
to use the indirect method, in which fresh whole blood was derived from a source other than 
the patient whose serum, was to be tested.  Heat inactivation of such stored sera was not 
required.  Para-aminobenzoic acid to make a  concentration of 5 rag. per cent was added to 
sera taken during sulfonamide therapy.  The most sensitive test zone for bacteriostasis of 
the cultures used was found to be 101 through 10  -e dilutions.  The technique was that of 
Todd (18)  as modified by Ward (19).  Because of a  possible prozone effect as reported by 
Thomas and Dingle  (20)  in studies on meningococcal infections, various dilutions of  sera 
were also employed.  The test consisted of determining the specific property of convalescent 
serum for sensitizing group A streptococci of homologous or heterologous types to the phago- 
cytic action of the leukocytes contained in whole blood.  To each tube (100 X  7 ram.) were 
added 0.25 cc.  of human heparinized blood obtained within the previous 2 hours, 0.05  cc. 
of  a  culture dilution,  and 0.05  cc.  of  varying concentrations of  serum.  Undiluted serum 
and serum diluted 1:10 and 1:100 were used.  Each concentration of serum was tested against 
tenfold serial dilutions of the culture ranging from 10  -s through 10  -6.  To find out whether 
the whole blood used inhibited the growth of streptococci,  control tubes containing saline 
solution in place of convalescent serum were always included.  The tubes were sealed with 
sterile, tightly-fitting rubber stoppers with a  smooth lower surface and incubated at 37  ° C. 
in an electrically driven mixing machine which rotated the tubes on the long axis at 8 R.p.x~. 
After 3 hours, a sample of each mixture was removed with a platinum loop 3 ram. across, and 
streaked evenly over one quadrant of a  rabbit blood agar plate which was incubated for 18 
to 24 hours.  The resulting growth was recorded as follows: growth covering the quadrant, 
++++;  three-fourths, +++;  one-half, ++;  and one-quarter, +; fewer than 10 colonies 
were represented in arabic numerals; 0 indicated no growth (Fig. 1). 
EXPERIMENTAL  RESULTS 
The  bacteriostatic  activity  of  sera  obtained  in the  acute  and  convalescent 
phases against each patient's own strain of streptococcus is recorded in Table I. 
These  sera  included  those  obtained  when  the patients  were  admitted  to  the 
hospital~ when antibodies first appeared, when the antibody level was highest, 
and when the patients were last seen.  A  distinct di~erence between acute and 
convalescent  phase  sera  is  apparent.  The  bacteriostatic  antibodies  first  ap- 
i The author wishes to acknowledge the courtesy of Dr.  S.  Z. Levine of the New York 
Hospital, Dr. A. De Forest Smith of the New York Orthopedic Hospital, and Dr. Philip D. 
Wilson of the Hospital for Special Surgery and their respective staffs for permission to obtain 
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peared in the blood of the patients between 3 and 5 weeks following infection, 
did not attain their maximal concentration until convalescence was well ad- 
vanced, and persisted in the sera of 2 of these patients for at least 37 weeks. 
In many tests done in duplicate and on different days with various samples 
of children's whole  blood,  the  findings were  reliable  and  reproducible.  In 
several instances, after a  loopful of the mixture was removed for streaking 
on the blood agar plate, the remainiI~g contents of the tubes were subcultured 
in blood broth, which uniformly remained sterile when no growth appeared on 
the plate.  This indicated that the streptococci had been killed and not tem- 
porarily  inhibited. 
In the subsequent experiments, samples of sera were taken at various inter- 
vals during convalescence and not necessarily when the antibodies were at the 
highest level, since sufficient serum was not always obtained at that period. 
The tests were repeated with strains other than that with which each patient 
was infected, although of the same serological type; the results of these tests 
are summarized in Tables IIa, IIb, and IIc.  These experiments show that 
each convalescent serum tested possessed antibodies for at least 7 strains of 
the same type as that which caused the patient's disease.  Within each series 
the susceptibility of the streptococci to bacteriostasis was strikingly uniform, 
except for those recorded in Table IIc where slight variability occurred. 
Lancefield (12) has found that many group A streptococci in the matt phase 
have at least two type-specific antigens, designated M and T, but some strains 
have only M, as reported by Elliott  (21)  and Lancefield and Stewart  (22). 
In the strains used in this experiment, M  and T  antigens were present in all 
except the following: strain D6C (type 19) in Table IIb; strain Cl18 (type 26), 
which caused the infection of the patient from whom the serum was obtained, 
and strain 11RS50  (type 26) in Table IIc; these contained only the M  com- 
ponent.  Despite  differences in  antigenic  composition,  the  degree  of  bacte- 
riostasis was essentially the same.  This observation suggests that M  and its 
corresponding antibody rather than T  and its antibody are concerned in this 
test.  Evidence has also been presented by Lyons and Ward  (23)  that the 
anti-M precipitin is probably identical with the specific opsonin which brings 
about opsonization of hemolytic streptococci of human origin. 
In order to test this hypothesis, a series  of strains with serologically related 
T and different M antigens (24) was employed.  Serum from a patient infected 
with a type 19 strain which contained both M and T antigens was tested with 
types 15, 17, 19, 23, and 30 streptococci, as illustrated in Table III.  The type 
19 strains, J17D and 1RSC42, with the same M antigen, had almost identical 
susceptibility to the type 19 serum; but the remaining strains with different M 
antigens, even though all contained at least one serologically identical T  com- 
ponent, grew equally well in  the  presence  of this patient's  serum.  Strains 
with only the T  antigen cannot be studied under these test conditions; such SIDNEY I~OTIIBAI~D  97 
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strains are in the glossy phase and are therefore susceptible to bacteriostasis by 
normal whole blood without the addition of convalescent serum.  The possi- 
bility that the T  antigen might have been masked by the M  in these cultures 
grown at 37°C. is ruled out because T  substance was demonstrable in cultures 
at this temperature in 4 of the 6 strains.  The remaining 2 could not be tested 
for T because of the granularity of the culture suspension.  Thus, the T antigen 
apparently had no importance in the bacteriostasis of the streptococci tested. 
TABLE  II a 
Bacgeriestasis of Type 6 Strains from Different Sources in Serum from a Patient Infected 
with Type 6 Strain 1RSC86 
Strain* 
1RSC85 
D  206 
C  166 
C  108 
F  96 
10RS28 
C  209 
D  182A 
Group A type 6 streptococci 
Source 
Scarlet fever and rheumatic fever 
Rockefeller Hospital (1943) 
Scarlet fever 
Roumanian strain No. 6121 
Dr. Schwentkcr (1938) 
Acute pharyngitis 
Rockefel]er Hospital (1942) 
Rheumatic fever 
Newport Naval Station No. 12946 (1942) 
Scarlet fever 
Roumanian strain 
Dr. Gordon (1935) 
Rheumatic  fever 
Rockefeller Hospital (1941) 
Rheumatic fever 
Bellevue Hospital (1942) 
Rheumatic fever 
Rockefeller Hospital (1939) 
Convalescent 
serum from pa- 
tient  with type 6 
infection strain 
1RSC86 
Undiluted serum 
Control: no serum 
Undiluted serum 
Control: no serum 
Undiluted serum 
Control: no serum 
Undiluted  serum 
Control: no serum 
Undiluted serum 
Control: no serum 
Undiluted  serum 
Control: no serum 
Undiluted serum 
Control: no serum 
Undiluted  serum 
Control: no serum 
Dilution of culture 
++  +  o  o 
++++  ++++  +++~  ++- 
++~  +  2  o 
++++  ++++  +++m  ++4 
++  3  3  0 
++++  ++++  +++  +++ 
++&  3  1  0 
++++  ++++  +++  ++~ 
++&  5  3  0 
++++  ++++  +++  +++ 
++  9  2  o 
++++  ++++  +++  ++~ 
++  +  o  o 
++++  +++  +++  +++ 
++  +  0  0 
++++  +++~  +++~  +++ 
* All strains have both M  and T  antigens. 
The type-specificity of the antibodies in these convalescent sera was further 
tested with 2 strains of heterologous types having both M and T antigens differ- 
ent from those in the patient's own strain.  The results shown in Table IV 
indicate definite type-specificity because no significant cross-reactions with the 
heterologous types were observed, although in serum from the patient infected 
with type 19, a slight degree of stasis occurred in the 10  -s dilution of type 26 
streptococci.  Sera from all 3 patients, in dilutions as high as 1:100 inhibited 
the  growth  of the homologous types; in addition,  data not recorded in this 
table  showed that bacteriostasis  occurred in  1:1,000 dilution of serum from TABLE  II b 
Baaeriostasis of Type 19 Strains from Different Sources in Serum from a Patient Infected 
with Type 19 Strain  1RSC42 
Group A type 19 streptococci 
Strain  Source 
IRSC42 
16RS6 
C 23A 
C 272 
C 296 
D 6C 
[t31/0/4 
H 106A 
Convalescent 
Antlgenic  serum from pa- 
compo-  tient with type 19 
nents  infection strain 
1RSC42 
Scarlet fever  M  and T  Undiluted serum 
Rockefeller  Hospital (1943)  Control:  no serum 
Acute pharyngitis  M and T  Undiluted serum 
Rockefeller  Hospital (1941)  Control:  no serum 
Scarlet fever  M  and T  Undiluted serum 
Halifax epidemic (1941)  i  Control: no serum 
i 
I 
New Haven epidemic (1942)  !  M and T  Undiluted serum 
Control: no serum 
Carrier strain  I  M and T  Undiluted serum 
Dr. Kuttner (1942)  Control:  no serum 
Acute tonsillitis  M  Undiluted serum 
Dr. Griflith  (1936)  Control: no serum 
Rheumatic fever  M and T  Undiluted serum 
Rockefeller  Hospital (1933)  Control: no serum 
Scarlet fever  M and T  Undiluted serum 
Dr. Tillett (1934)  I  Control: no serum 
Dilution of culture 
I0-:  10-4  I0-~  I0-* 
+  I  0  0 
++++  ++++  +++  ++4. 
+  1  0  0 
++++  ++++  +++4.  +++ 
6  I  0  0 
++++  ++++  +++  +++ 
+  0  0  0 
++++  +++  +++  +++ 
+  3  0  0 
++++  ++++  +++  + 
4  0  0  0 
++++  ++++  +++4.  +++-* 
+  0  0  0 
++++  +++  +++  +++ 
+4-  0  0  0 
++++  +++  +++  +++ 
TABLE  II c 
Baderlostazis of Type 26 Strains from Different Sources in Serum from a Patient Infected 
with Type 26 Strain  C 118 
Group A type 26 streptococci 
Strain 
118 
56O 
383 
508 
RSSt 
tSCI )8 
RS6( 
RSI.' 
Source 
Rheumatic fever  M 
Rockefeller  Hospital (1942) 
Acute tonsillitis  M  and T 
Camp Borden Hospital 
Canada (1943) 
Scarlet fever  M and T 
Japan (1939) 
i Toe infection  M  and T 
New Haven Hospital (1943) 
Rheumatic fever  M 
Rockefeller  Hospital (1941) 
Scarlet fever  M and T 
Rockefeller  Hospital (1943) 
Rheumatic fever  M and T 
Rockefeller  Hospital (1942) 
Acute pharyngitis  M and T 
Rockefeller  Hospital (1941) 
Convalescent 
Antigenic  serum from pa- 
compo-  tient with type 26 
nents  infection strain 
C 118 
Undiluted serum 
Control: no serum: 
Undiluted serum 
Control: no serum 
Dilution of culture 
10-3  10-4  I0  ~  I01 
+  0  0  0 
++++  ++++  +++  ++4- 
2  2  0  0 
++++  ++++  +++  +++ 
Undiluted serum  +++ 
Control:  no serum  ++++ 
Undiluted serum  +4.4- 
Control:  no serum  ++++ 
Undiluted serum  ++-g 
Control: no serum  ++++ 
Undiluted serum  ++4. 
Control: no serum  ++++ 
Undiluted serum  +-4- 
Control: no serum  ++++ 
Undiluted serum  ++4- 
Control: no serum  ++++ 
++  2  0 
+++4.  +++  ++4. 
+  2  0 
+++  +++  +++ 
+  2  0 
++++  +++  +++ 
+4.  0  0 
++++  +++  +++ 
6  3  0 
+++  +++  ++-4- 
+  0  0 
÷÷+4.  +++  +++ 
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the patient infected with type 6 streptococci.  Serum from the patient con- 
valescent from type 26 infection was tested with strains of 5 other heterologous 
types: types 4  (strain T  4), 24  (strain C  115), 28  (strain D140A), 29 (strain 
D  23),  and  46  (strain  C  105);  no  bacteriostasis  of these  streptococci  was 
observed. 
TABLE  III 
Ba~teriostasis of a Series  of Strains of Group A  Streptococci with Rdated  T  but Distinct M 
Antigens 
Type and strain of group A 
streptococci 
Type 15 
(strain T  15) 
Type 17 
(strain J  17E) 
Convalescent  serum from 
]?atieut with type 19 
infection strain  IRSC42 
Undiluted serum 
1 : 10 dilution 
Control: no serum 
Undiluted serum 
1 : 10 dilution 
Control: no serum 
Dilution of culture 
10-s  i0-~  I0  ~  I0~ 
++++  ++++  +++~  ++4- 
++++  ++++  +++4-  ++~ 
++++  ++++  ++++  ++~ 
++++  ++++  ++++  +++ 
++++  ++++  +++~  +++ 
++++  ++++  ++++  ++ 
Type 19 
(strain Jr 17D) 
Type 19 
(strain 1RSC42) 
Type 23 
(strain T  23) 
Type 30 
(strain D  11) 
Undiluted serum 
1 : 10 dilution 
Control: no serum 
Undiluted serum 
1 : 10 dilution 
Control: no serum 
Undiluted serum 
1 : 10 dilution 
Control: no serum 
Undiluted serum 
1 : 10 dilution 
Control: no serum 
8  0  0  0 
5  0  0  0 
++++  ++++  +++  ++4- 
9  0  0  0 
8  0  0  0 
+-b-I-+  +-J-+  -b++  ++4- 
+++  ++  ++±  + 
+++~  +++  ++~  + 
++++  +++  ++~  + 
++++  ++++  +++  +++ 
++++  ++++  +++  +++ 
++++  ++++  +++  ++~ 
It  seemed  desirable  to  ascertain  whether  the  type-specific bacteriostatic 
antibodies in these sera could be absorbed with the homologous or heterologous 
type strains  used  in  the preceding experiment.  The sera  were  mixed with 
heat-killed streptococci, in the proportion 3 parts serum to 1 part packed bac- 
terial cells, and incubated in a water bath at 37 ° C. for 30 minutes; then stored 
overnight at 4 ° C.  After centrifugation, the clear supernatant sera were re- 
moved.  Samples  of each  serum  were  tested  in  the  unabsorbed  state  and 
after absorption with strains of the homologous and two heterologous types, 
respectively.  Table V demonstrates that in each case the bacteriostatic anti- SIDI~EY  ROYIIBARD  101 
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bodies were almost completely removed from the sera by the homologous strep- 
tococcal cells, but that they were relatively unaffected  by strains of the heterolo- 
gous types.  Again the uniform results illustrate that the bacteriostasis effected 
by the convalescent sera is type-specific. 
Sera from 48 patients with a total of 54 group A streptococcal infections have 
been tested by this method for type-specific antibodies and only rarely have 
cross-reactions been found.  A detailed report of this study with a comparison 
of the clinical findings and the antibody response will be presented later. 
DISCUSSION 
The foregoing experiments show that human  convalescent sera from 3 adults 
contained  type-specific  streptococcal antibodies demonstrable  by the indirect 
bacteriostatic method.  This procedure, which required that fresh serum and 
leukocytes from another human source be added to the test sera, is probably 
better for testing sera from adults than is the direct method, because whole 
blood from older individuals without recent infections often has bacteriostatic 
properties for many strains of streptococci, as observed both in this laboratory 
and by Lyons and Ward (23).  Kuttner and Lenert (14),  on the other hand, 
observed type-specific bacteriostatic properties by both the indirect and direct 
methods, but analyzed only children's blood which probably does not contain 
the so called "natural specific opsonins" present in adult blood (23). 
To avoid the difficulties inherent in methods involving phagocytosis, and to 
insure proper standardization of the technique, it is imperative that all strains 
grow satisfactorily in the whole blood to which the test serum has not been 
added.  Young cultures must also be used, as noted by earlier investigators 
(23,  25-28)  who  observed  that  such  cultures  are  more  resistant  to  phago- 
cytosis than those tested after longer incubation.  Another important factor 
is the prevention of bacterial dissociation, for inconsistent results inevitably 
occur when different variants of the same strain are studied. 
The  chief objection  to  the  indirect method is  the  difficulty of obtaining 
enough whole blood to study many sera.  Unfortunately, as recorded later 
(29), whole blood from certain laboratory animals could not be substituted for 
human blood.  In spite of the inherent difficulties in the indirect bacteriostatic 
technique, this method of testing human adult sera is preferable to the precipitin 
test or to the complement fixation test because it shows no cross-reactions and 
apparently yields type-specific results.  The streptococcidal property of acute 
phase sera from febrile patients with various diseases, as described by Tillett 
(30),  was not observed.  The relative amount of serum used, however, was 
much less than in Tillett's experiments, and the sera had been stored in the 
ice  box much longer before  testing. 
The significance of the type-specificity observed in this study is emphasized 
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were from many parts of the world and from infections occurring over a  10 
year period.  Heretofore, experiments of this nature have been limited to the 
study of strains from localized geographical areas.  The absorption experi- 
ments provide the most convincing evidence for specificity: the homologous 
antibodies were always specifically absorbed from the serum.  Because absorp- 
tion was successful in these bacteriostatic tests, it may prove possible to apply 
similar absorption methods to the precipitin technique which shows many cross- 
reactions.  In our experience thus far, all precipitin reactivity in human sera, 
which is usually of low titre, has been removed by absorption with heterologous 
as well as homologous type heat-killed cultures.  Perhaps if after absorption 
the precipitin tests were performed according to the technique of Heidelberger 
and Anderson  (31)  with large amounts of absorbed  sera  and with a  longer 
period in the ice box, cross-reactions might be avoided and homologous reac- 
tivity  retained. 
The type-specificity of human sera in the bacteriostatic test appears to be 
dependent upon M-anti-M reactions and not upon T-anti-T; and it is probably 
comparable  to  the  type-specific protection  of mice by hyperimmune rabbit 
sera, in which the antibody to the M protein is one of the factors involved (32). 
It is evident,  therefore, from these  data that type-specific antibodies are 
demonstrable in human sera.  Although sera from only 3 patients were investi- 
gated, the fact that these tests were made with numerous samples of sera with 
a variety of homologous and heterologous streptococci and supported  by ab- 
sorption  experiments  lends  weight  to  these  observations  concerning  type- 
specificity. 
SUMMARY 
1.  Type-specific antibodies were demonstrated by the indirect bacteriostatic 
test in sera from human adults convalescing from group A streptococcal infec- 
tion of the upper respiratory tract.  The time of appearance of the antibodies 
varied from 3 to 5 weeks; and they persisted in 2 patients for at least 37 weeks 
after the onset of the infection. 
2.  The specificity of the antibody response  in one serum was tested with 
strains of 7 heterologous types; in another, with 6; and in the third, with 2; 
but in no instance were cross-reactions observed.  Moreover, each convalescent 
serum showed approximately equal bacteriostasis for 7 different strains of the 
same type as that which caused the infection. 
3.  The antibodies were specifically absorbed from the serum by homologous 
heat-killed streptococci, but not significantly by strains of heterologous types. 
4.  The specific M  antigen of the streptococcal cell with its respective anti- 
body, and not the T  substance, appeared to be concerned in the reaction. 
5.  Ir~ spite of numerous technical difficulties inherent in the method, this 
bacteriostatic test provides a  useful procedure for studying type-specific im- 
munity in streptococcal infections. SIDNEY I~OI~m~ARD  105 
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EXPLANATION OF PLATE 4 
The photographs  were made by Mr. Joseph B. Haulenbeek. 
FIo. 1.  Blood agar plates  showing results of an experiment in which convalescent 
serum from a patient recovering from a group A, type 6 streptococcal  infection was 
tested with strains of the homologous and two heterologous types of streptococci. TIlE  JOURNAL OF EXPERIMENTAL  MEDICINE  VOL.  82  PLATE  4 
(Rothbard:  Effect of human sera on group A  streptococci.  I) 